The global sleep disorder treatment drugs market is anticipated to grow as the general public and governments become more aware of sleep problems. The growing number of people suffering from a variety of sleep disorders, including hallucinations, sleep paralysis, interrupted nocturnal sleep, insomnia, sleep apnea, narcolepsy, and circadian abnormalities, has drawn the attention of governments across the globe, pushing them to take action. Various networks, such as the National Center for Sleep Disorders Research, have run awareness campaigns to address the needs of those with serious or mild sleep disorders.
Additionally, key market players approval by government authority such as the FDA and commercialization of new drugs are also contributing to driving the market growth during the forecast period. For an instance, In March 2019, Sunosi (solriamfetol) was approved by the US Food and Drug Administration for the treatment of narcoleptic patients. However, a lower diagnosis rate, a lower treatment rate, and the adverse effects of sleep disorder medications may hinder demand for sleep disorder treatment drugs.
Among the application segment, insomnia is expected to dominate the global sleep disorders treatment market. The attributable factor for the growth of the segment is an increase in the prevalence of insomnia, which causes severe, uncontrollable daytime sleepiness as well as a loss of muscle tone. According to the National Institutes of Health, nearly 30% of the general population has sleep disruption, with approximately 10% experiencing daily functional impairment compatible with the diagnosis of insomnia. The factors expected to fuel this segment's growth during the forecast period include increased knowledge of the disease and available treatment choices, which will lead to early diagnosis of the condition.
To Request a Sample of our Report on Sleep Disorder Treatment Drugs Market: https://www.omrglobal.com/request-sample/sleep-disorder-treatment-drugs-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Takeda Pharmaceutical Co., Ltd., Merck & Co., Inc., and Mylan NV, among others.
Sleep Disorder Treatment Drugs Market Report by Segment
By Drug Type
- Benzodiazepines
- Nonbenzodiazepines
- Antidepressants
- Other
By Application
- Insomnia
- Sleep Apnea
- Narcolepsy
- Circadian Disorders
- Others
A full Report of Sleep Disorder Treatment Drugs Market is Available @ https://www.omrglobal.com/industry-reports/sleep-disorder-treatment-drugs-market
Sleep Disorder Treatment Drugs Market by Region
North America
- United States
- copyright
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/sleep-disorder-treatment-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404